Eye drops to reduce redness from glaucoma treatment
Part of Eyes & vision, Heart & circulation clinical trials.
This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have open-angle glaucoma or ocular hypertension (high eye pressure)
- You have been using the glaucoma drop netarsudil/latanoprost for at least 2 to 6 weeks
- You have noticeable eye redness (grade 2 or higher on the Efron redness scale) from your current drops
- You are willing to switch to a different version of your current drop or add a new drop
- You can self-administer eye drops or have someone help you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether Lumify™ eye drops affect eye redness, eye pressure, and eyelid position in people with primary open-angle glaucoma. It may help doctors understand how “whitening” eye drops could interact with glaucoma treatment and symptoms.
This study looks at how certain glaucoma eye drops affect the surface of your eye. It tests a new implant that may reduce damage and improve comfort.
This study uses a special camera (Brillouin microscopy) to measure how stiff your cornea is. It compares people with different types of glaucoma to those without glaucoma, helping researchers understand the link between corneal stiffness and eye pressure.
This study tests an experimental eye drop to see if it can reduce eye redness compared to a placebo drop. If you often use redness relief drops or would like to, this trial might help you find a new option.
This trial tests an eye drop that may reduce redness in adults who often use redness relief drops or are interested in them. If you qualify, you might get either the study drop or a placebo to see if it works.
This trial tests if brimonidine eye drops can slow down worsening nearsightedness (myopia) in children aged 6 to 14. If your child has mild to moderate myopia and no other eye problems, they may be able to join.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.